ENEA 2010: neuroendocrine tumours

Dr Simona Grozinsky-Glasberg speaks about her work with neuroendocrine tumours and explains why she believes that investigating mTOR will be an important step towards developing a successful treatment. Dr Grozinsky-Glasberg discusses the current standard treatment for these tumours, outlines the different factors that must be taken into account when deciding which drugs should be used and speaks about exciting new drugs in development.

Dr Simona Grozinsky-Glasberg of the Rabin Medical Center in Petah Tikva, Israel and the Tel Aviv University in Israel, speaking at the 2010 European NeuroEndocrine Association congress in Liege.

• Kategorija